Synapse - Raajit Rampal

Results (351)

High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy

Meeting Abstract

Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
Blood (2013)

Fulltext@MSK | Save

BRAFV600E mutations occur in the hematopoietic stem cell compartment in hairy cell leukemia

Meeting Abstract

Chung, S. S.; Park, J. H.; Kim, E.; Chung, Y. R.; Hu, W.; Lito, P.; Feldstein, J. T.; Rampal, R. K.; Telis, L.; Patel, M.; more...
Blood (2013)

Fulltext@MSK | Save

Improved efficacy of combination of JAK2 and Hedgehog inhibitors in myelofibrosis

Meeting Abstract

Bhagwat, N.; Keller, M. D.; Rampal, R. K.; Shank, K.; de Stanchina, E.; Rose, K.; Amakye, D.; Levine, R. L.
Blood (2013)

Fulltext@MSK | Save

Leveraging cancer genome information in hematologic malignancies

Journal Article

Rampal, R.; Levine, R. L.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia

Journal Article

Baljevic, M.; Abdel-Wahab, O.; Rampal, R.; Maslak, P. G.; Klimek, V. M.; Rosenblat, T. L.; Douer, D.; Levine, R. L.; Tallman, M. S.
Acta Haematologica (2013)

Fulltext@MSK | Save

Development of a murine model for leukemic transformation of myeloproliferative neoplasms for preclinical therapeutic studies

Meeting Abstract

Rampal, R. K.; Pandey, S.; Abdel-Wahab, O.; Tsai, J. J.; Manshouri, T.; Park, C. Y.; Verstovsek, S.; Levine, R. L.
Blood (2012)

Fulltext@MSK | Save

Progression of RAS-mutant leukemia during RAF inhibitor treatment

Journal Article

Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
New England Journal of Medicine (2012)

Fulltext@MSK | Save

Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): Formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium

Journal Article

Mascarenhas, J.; Heaney, M. L.; Najfeld, V.; Hexner, E.; Abdel-Wahab, O.; Rampal, R.; Ravandi, F.; Petersen, B.; Roboz, G.; Feldman, E.; more...
Leukemia Research (2012)

Fulltext@MSK | Save

Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome